Adverse nonmotor outcomes are prevalent in younger adults up to 6 months after stroke — even in those with favorable functional recovery scores on standard scales. In a prospective trial of about 500 ...
A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...